Pregnancy-relevant infections—from TORCH pathogens (Toxoplasma, Rubella, CMV, HSV-1/2) and “Other” agents (syphilis, parvovirus B19, varicella-zoster) to HIV, hepatitis B/C, Chlamydia trachomatis, Neisseria gonorrhoeae, Group B Streptococcus (35–37-week screen), and regionally important arboviruses (Zika, dengue, chikungunya)—require rapid, reliable diagnostics to protect mother and fetus. At Southern Medical Supplies Limited (SMSL), we deliver an end-to-end testing workflow: ELISA/chemiluminescent serology with IgM/IgG and IgG avidity (for primary infection dating in toxoplasma/rubella/CMV), NAAT/RT-PCR for acute and congenital infection confirmation (maternal blood, urine, amniotic fluid as indicated), targeted rapid tests, culture & susceptibility (e.g., selective broth for GBS), and confirmatory immunoblot/IFA where required—plus immunity screens (rubella/varicella IgG) and adjunct markers to inform prophylaxis and therapy. Our portfolio spans platforms sourced from a broad network of trusted partners—EUROIMMUN, Ansh Labs, Randox, Streck, Bio-Rad, Abbott, Roche, Siemens Healthineers, Qiagen, bioMérieux, Cepheid, Werfen, Globe Scientific, ELGA LabWater, LW Scientific, Sebia, LTA SRL, Acrobiotech, MAKOL Innovacion Medica, Rayto Life and Analytical Sciences, Diazyme, Hardy’s Diagnostics, and Teco Diagnostics—delivering the sensitivity, specificity, and reproducibility clinicians need for early detection, risk stratification, timely prophylaxis (e.g., intrapartum GBS), and optimized maternal–fetal outcomes.